Read on Twitter
I highlighted #GDR last week at 90p I am highlighting #TILS this week!
2nd wave threat level is high & lock down is possible. How long can this go on for? Money still going into covid stocks to hedge.
How many vaccines for covid? Big fat 0
Testing and treatment is key!
2nd wave threat level is high & lock down is possible. How long can this go on for? Money still going into covid stocks to hedge.
How many vaccines for covid? Big fat 0
Testing and treatment is key!
#TILS huge announcement: Clinical Study with Nasally Administered Foralumab! Fully Human Anti-CD3 Monoclonal Antibody, for Treatment of COVID-19 Patients in Brazil.
Nasal Adminsteration of Foralumab is a potentially TRANSFORMATIVE approach for treating patients with COVID-19.
Nasal Adminsteration of Foralumab is a potentially TRANSFORMATIVE approach for treating patients with COVID-19.
#TILS they also have the IL6 trial - developing an inhalation technology for direct delivery of the antibody into the lungs using a handheld inhaler or nebulizer for treatment of patients with COVID-19.
4 agreements signed with research organisations.
4 agreements signed with research organisations.
#TILS
Currently 141p
304p 52 week high
Placing at 200p £50m
Phase II trials to begin in Foralumab (Oral & Nasal)
TZLS-501 - only human IL6 MaB therapeutic
Phase III Extensive Patent estate
Market opportunity for mAb therapeutics is greater than $110 billion
Currently 141p 304p 52 week high Placing at 200p £50m Phase II trials to begin in Foralumab (Oral & Nasal) TZLS-501 - only human IL6 MaB therapeutic Phase III Extensive Patent estate Market opportunity for mAb therapeutics is greater than $110 billion
#TILS recent podcast
2 trials in covid, but the Nasally Administered Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, for Treatment of COVID-19 Patients in Brazil (1 of biggest hotspot) to start in next 2 weeks!
Should rerate like #SNG & #DDDD
2 trials in covid, but the Nasally Administered Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, for Treatment of COVID-19 Patients in Brazil (1 of biggest hotspot) to start in next 2 weeks!
Should rerate like #SNG & #DDDD
#TILS it is essential to have drug therapy parallel with vaccine.
AstraZeneca vaccine showed side effects so having focus on vaccine is dangerous & they also have low compliance rate.
Having emergency drug therapy to treat patient from respiratory failure is essential!
AstraZeneca vaccine showed side effects so having focus on vaccine is dangerous & they also have low compliance rate.
Having emergency drug therapy to treat patient from respiratory failure is essential!
